Clinical Trials

Find trials by condition, location & phase

Drug Monographs

Browse drug monographs and information

Explore organizations and their profiles

Latest updates on trials and healthcare

Approved products by global authorities

AI-Powered Research

Discover powerful insights with advanced AI analysis tools for clinical trials.

Premium Access

Get unlimited access to our comprehensive pharmaceutical database and analytics.

University Health Network

🇨🇦Canada

Country: 🇨🇦Canada

Ownership: Private

Established: 1999-01-01

Employees: 10K

Market Cap: -

Website: http://www.uhn.ca

Clinical Trials

Feasibility Study of Genomic Profiling Methods and Timing in Tumor Samples

Completed

Conditions: Colorectal Cancer
Gynecological Cancer
Breast Cancer
Metastatic
Eligible for Phase I or Phase II Study
Melanoma Cancer

First Posted Date: 2012-10-10

Last Posted Date: 2018-05-09

Lead Sponsor: University Health Network, Toronto

Target Recruit Count: 45

Registration Number: NCT01703585

Locations: 🇨🇦
Princess Margaret Cancer Centre, Toronto, Ontario, Canada

Busulfan & Melphalan Conditioning for Autologous Stem Cell Transplant (ASCT) and Lenalidomide Maintenance

Phase 2

Completed

Conditions: Multiple Myeloma

Interventions: Drug: Busulfan
Drug: Melphalan
Drug: Lenalidomide

First Posted Date: 2012-10-08

Last Posted Date: 2022-09-21

Lead Sponsor: University Health Network, Toronto

Target Recruit Count: 78

Registration Number: NCT01702831

Locations: 🇨🇦
Saint John Regional Hospital, 5DN Research Department, 400 University Ave, Saint John, New Brunswick, Canada
🇨🇦
Cross Cancer Institute 11560 University Ave, Edmonton, Alberta, Canada
🇨🇦
Queen Elizabeth II Health Sciences Centre., Halifax, Nova Scotia, Canada

and more 7 locations

Regulation of Intestinal and Hepatic Lipoprotein Production by Glucose and Fructose

Not Applicable

Completed

Conditions: Hyperlipidemia

Interventions: Other: Intraduodenal glucose or fructose

First Posted Date: 2012-09-27

Last Posted Date: 2015-03-10

Lead Sponsor: University Health Network, Toronto

Target Recruit Count: 14

Registration Number: NCT01694446

Locations: 🇨🇦
Toronto General Hopital, Toronto, Ontario, Canada

Optical Coherence Tomography for Monitoring Late Oral Radiation Toxicity After Radiotherapy of Head and Neck Cancer Patients

Completed

Conditions: Abnormalities, Radiation-Induced

First Posted Date: 2012-09-25

Last Posted Date: 2021-04-05

Lead Sponsor: University Health Network, Toronto

Target Recruit Count: 20

Registration Number: NCT01692600

Locations: 🇨🇦
Princess Margaret Hospital/UHNTorotno, Toronto, Ontario, Canada

Degarelix Neo-Adjuvant Radical Prostatectomy Trial

Phase 2

Completed

Conditions: Prostate Cancer

Interventions: Drug: Degarelix
Drug: Casodex
Drug: LHRH Agonist

First Posted Date: 2012-08-28

Last Posted Date: 2015-12-22

Lead Sponsor: University Health Network, Toronto

Target Recruit Count: 35

Registration Number: NCT01674270

Locations: 🇨🇦
Vancouver General Hospital, Vancouver, British Columbia, Canada
🇨🇦
University Health Network, Toronto, Ontario, Canada

A Trial of ASP7487 (OSI-906) in Combination With Bortezomib for the Treatment of Relapsed Multiple Myeloma

Phase 1

Terminated

Conditions: Multiple Myeloma

Interventions: Drug: ASP7487, Velcade, Dexamethasone

First Posted Date: 2012-08-27

Last Posted Date: 2018-09-13

Lead Sponsor: University Health Network, Toronto

Target Recruit Count: 19

Registration Number: NCT01672736

Locations: 🇺🇸
Emory University Winship Cancer Institute, Atlanta, Georgia, United States
🇺🇸
University Of Chicago Medical Center, Chicago, Illinois, United States
🇨🇦
Hôpital Maisonneuve-Rosemont, Montreal, Quebec, Canada

and more 3 locations

Study of Red Bull™ Sugar-Free Drink for Reduction of Fatigue in Prostate Cancer Patients Receiving LHRH Agonist Therapy

Phase 2

Completed

Conditions: Fatigue

Interventions: Other: Red Bull™ Sugar-Free Drink

First Posted Date: 2012-08-21

Last Posted Date: 2013-12-19

Lead Sponsor: University Health Network, Toronto

Target Recruit Count: 20

Registration Number: NCT01669460

Locations: 🇨🇦
University Health Network, Toronto, Ontario, Canada

Effect of Superficial Cervical Plexus Block on the Postoperative Quality of Recovery

Not Applicable

Completed

Conditions: Cervical Disc Prolapse

Interventions: Other: Superficial cervical plexus block for experimental group

First Posted Date: 2012-08-10

Last Posted Date: 2018-02-06

Lead Sponsor: University Health Network, Toronto

Target Recruit Count: 46

Registration Number: NCT01662219

Locations: 🇨🇦
Toronto Western Hospital,UHN., Toronto, Ontario, Canada

Put a Face to a Name (Part A): The Effects of Photographic Aids on Patient Satisfaction, Clinician Communication, and Quality of Care

Not Applicable

Completed

Conditions: Effects of Photographic Aids (Photos of Faces) on Patient Recall of Their Clinical Care Team
Effects of Photographic Aids (Photos of Faces) on Clinician-patient Communication
Effects of Photographic Aids (Photos of Faces) on Overall Patient Satisfaction

Interventions: Other: Provision of Clinical Care Handout

First Posted Date: 2012-08-07

Last Posted Date: 2014-04-07

Lead Sponsor: University Health Network, Toronto

Target Recruit Count: 256

Registration Number: NCT01658644

Locations: 🇨🇦
Toronto General Hospital, Toronto, Ontario, Canada

Canadian Biomarker Integration Network for Depression Study

Phase 3

Completed

Conditions: Major Depressive Disorder

Interventions: Drug: escitalopram
Drug: aripiprazole

First Posted Date: 2012-08-02

Last Posted Date: 2018-05-11

Lead Sponsor: University Health Network, Toronto

Target Recruit Count: 211

Registration Number: NCT01655706

Locations: 🇨🇦
University of British Columbia, Vancouver, British Columbia, Canada
🇨🇦
University Health Network, Toronto, Ontario, Canada
🇨🇦
University of Calgary, Calgary, Alberta, Canada

and more 3 locations

© Copyright 2025. All Rights Reserved by MedPath

Home Terms & Conditions Privacy Policy